問卷

TPIDB > Principal Investigator

Principal Investigator


Chi Mei Medical Center

Division of Cardiovascular Diseases

更新時間:2025-10-18

曾冠叡
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

5Cases

2024-04-01 - 2026-09-01

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2025-09-30 - 2032-03-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Recruiting11Sites

2026-01-01 - 2031-09-18

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
15Sites

2022-01-19 - 2027-10-20

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2023-04-01 - 2032-12-31

Phase III

Active
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT)
  • Condition/Disease

    Primary Prevention of Atherosclerotic Cardiovascular Disease

  • Test Drug

    KJX839 (Inclisiran)

Participate Sites
9Sites

Recruiting9Sites